PeptidePedia The community reference

Contributions of LiraLotte

User contributions·30 logged edits·page 1 of 1

Contributions by LiraLotte, newest first. This list covers edits recorded in the site's change log; the editor's lifetime total of 2,055 edits includes activity predating the current log.

  1. 18:33, 18 Jul 2026 (diff | hist) Lixisenatide 4,195 ±0 reorder the analogues chronologically rather than alphabetically
  2. 06:13, 16 Jul 2026 (diff | hist) Tirzepatide 8,037 ±0 m the lead claimed weekly dosing for a compound dosed daily; corrected
  3. 02:47, 14 Jul 2026 (diff | hist) Cagrilintide 4,256 ±0 add the molecular formula to the infobox
  4. 06:45, 27 May 2026 (diff | hist) Amylin 5,795 ±0 ce
  5. 16:20, 9 Apr 2026 (diff | hist) Survodutide 5,445 ±0 expand §Status and material sold under the name
  6. 20:58, 28 Mar 2026 (diff | hist) Dulaglutide 5,490 ±0 split overlong sentence
  7. 10:55, 5 Feb 2026 (diff | hist) Semaglutide 10,355 ±0 m sentence case in headings per PP:MOS
  8. 13:30, 24 Jan 2026 (diff | hist) Talk:Liraglutide 611 +125 /* DPP-4 resistance: the article contradicted itself */ reply
  9. 16:08, 7 Jan 2026 (diff | hist) Amylin receptor agonist 5,245 ±0 m ce, tighten prose
  10. 10:01, 11 Nov 2025 (diff | hist) GLP-1 receptor agonist 11,264 ±0 convert a hard-coded date to the house format
  11. 19:13, 12 Sep 2025 (diff | hist) Semaglutide 9,799 ±0 expand §Material sold outside licensed supply
  12. 15:54, 30 Jun 2025 (diff | hist) Peptide content 8,131 +1,206 correct the resolution formula — the denominator is the sum of the widths
  13. 12:34, 21 Jun 2025 (diff | hist) Cagrilintide 4,052 +839 add CAS number, sourced
  14. 06:26, 19 Jun 2025 (diff | hist) Oral semaglutide 3,542 ±0 add the receptor targets to the lead sentence
  15. 10:27, 13 May 2025 (diff | hist) Dual incretin agonist 4,752 +18 m expand §Design problem
  16. 21:07, 11 May 2025 (diff | hist) Amylin receptor agonist 3,909 ±0 m reorder the analogues chronologically rather than alphabetically
  17. 09:05, 5 May 2025 (diff | hist) Orforglipron 4,505 +40 label the animal data as animal data in the sentence, not only in the section heading
  18. 17:09, 1 May 2025 (diff | hist) Placebo-adjusted effect 3,893 ±0 add the confidence interval to the point estimate
  19. 06:02, 30 Mar 2025 (diff | hist) Research use only 6,689 ±0 m expand §Legal position and importation
  20. 05:17, 13 Feb 2025 (diff | hist) Orforglipron 3,337 ±0 m typo
  21. 23:50, 5 Feb 2025 (diff | hist) Amylin 3,956 +23 expand §Receptors
  22. 04:47, 26 Jan 2025 (diff | hist) Retatrutide 5,700 +1,103 label the animal data as animal data in the sentence, not only in the section heading
  23. 20:49, 4 Jan 2025 (diff | hist) Vial filling and stoppering 2,773 +25 serial comma per PP:MOS
  24. 15:36, 25 Dec 2024 (diff | hist) ISO 9001 3,002 +553 m correct the description of the shortage-list mechanism
  25. 17:41, 28 Oct 2024 (diff | hist) Deamidation 1,364 ±0 add the note on co-elution and what it hides
  26. 03:36, 23 Oct 2024 (diff | hist) CagriSema 2,223 +562 m expand §Reported findings
  27. 07:31, 12 Oct 2024 (diff | hist) Oral semaglutide 2,537 +408 m give the INN alongside the trade name at first mention
  28. 10:48, 6 Oct 2024 (diff | hist) Exenatide 1,276 ±0 ce
  29. 12:07, 1 Oct 2024 (diff | hist) ISO 9001 2,417 +450 clarify that personal importation and commercial importation are different questions
  30. 08:14, 10 Sep 2024 (diff | hist) Retatrutide 3,350 +38 fix a broken wikilink